NeuroRinse
A single wearable module designed to support calm, steady focus throughout your day - without caffeine, without stimulants.
Daytime Clarity, Nighttime Calm
Mental fog isn't a diagnosis. It's a signal.
Most days, it doesn't announce itself. It shows up as the third cup of coffee that doesn't quite land, the afternoon slump that coffee can't touch, the sentence you lose halfway through saying it. You've been told this is just what a long day feels like. It might be something simpler: your circulation, quietly struggling to keep up with everything you're asking of it. One module, worn behind the ear, built for two moments in your day: a 16-minute reset with your focus slips, and a calming wind-down before bed.
How It Works
NeuroRinse is a wellness brand from NeuroRester, built on the same Bioboosti® platform behind our other devices. That platform's story begins well before this product did. Our work started in 2009 in Silicon Valley as Biomobie Corp., developing non-invasive Digital PEMF technology for circulatory wellness in collaboration with academic researchers. For years, that was the whole project: gentle, low-intensity signal delivery, studied over long durations.
NeuroRinse runs on a simple rhythm: 16 minutes, whenever you need it.
- Daytime reset - place it behind one for for a 16-minute session whenever the fog rolls in: mid-morning slump, post-lunch crash, before a big meeting.
- Before-bed wind-down - use the same device again in the evening. It calms an overactive mind and helps you fall into deeper sleep faster.
No separate settings, no complicated app confirguration to learn - the same 16-minute session, whenever your day (or night) calls for it.
Why NeuroRinse Exists
Most fixes for a foggy afternoon are blunt instruments: more caffeine, more stimulants, more force. NeuroRinse takes a different approach - supporting your body's own physiology rather than overriding it with chemistry.
What early users have told us they notice:
- Morings feel more "online" from the start
- Afternoons feel steadier, without the usual crash
- A subjective sense that thoughts feel less "sticky"
(These are self-reported impressions from early testers, not measured clinical outcomes - individual experience will vary)
Who it's for: knowledge workers navigating long stretches of deep focus, anyone managing a demanding daily cognitive load, and anyone who's rather feel steady without relying on caffeine to get there.
The Science
Over fifteen years, the Bioboosti® platform has been the subject of more than twenty clinical and overservational studies across circulatory, neurological, and metabolic wellness including research collaboartions with Mayo Clinic.
Published Research
Research examining the relationship between microcirculation, metabolic function, and circulatory wellness has been published two peer-reviewed papers (including publications in Blood Pressure and collaborative studies with Mayo Clinic researchers.
- The impact of pulsed electromagnetic field therapy on blood pressure and circulating nitric oxide levels: a double blind, randomized study in subjects with metabolic syndrome, Chul-Ho Kim, Courtney M. Wheatley-Guy, Glenn M. Stewart, Dongwook Yeo, Win-Kuang Shen & Bruce D. Johnson, 2019, 10.1080/08037051.2019.1649591.
- Impact of pulsed electromagnetic field therapy on vascular function and blood pressure in hypertensive individuals, Glenn M. Stewart, Courtney M. Wheatley-Guy, Bruce D. Johnson, Win K. Shen, Chul-Ho Kim, 2020, 10.1111/jch.13877.
Platform user base. Approximately 50,000 people have used devices built on the Bioboosti® platform to date. Aggregate feedback from this group informed the design of NeuroRinse, particularly the decision to build around continuous support rather than intermittent operation.
Areas of Investigation
- Circulatory and microvascular wellness. Long-term investigation of ultra-low-intensity PEMF and its relationship to everyday circulatory comfort.
- Rest and relaxation. Observational work examining relaxation and rest quality, in which long-term users reported positive trends in daily mental clarity and calm.
- Cellular energy dynamics. Research evaluating how gentle Digital PEMF interacts with cellular energy processes in the context of daily physical comfort and recovery.
Intellectual Property: A Decade of Innovation
Our patent portfolio reflects continuous evolution. Covering advanced Digital PEMF generation methods and 24/7 continuous application protocols.
In 2015, we were granted our first patent - focused on microcirculation modulation. It was the beginning: we knew the waveform worked, but the mechanism was still broad, still being mapped. Ten years of clinical research, PET imaging validation, and algorithmic refinement later, that broad beginning found its precise target. In 2026, our latest patent was issued - this time for a waveform-algorithm method related to myocardial microcirculation. From a general understanding of "circulation support" to a clinically validated, PET-imaged, heart-specific application. The same technology, traced to its source.
Proprietary Hardware and Waveform Architecture The signal architecture behind NeuroRinse is protected by two granted U.S. patents. U.S. 8,968,172 B2 (granted 2015) covers the core waveform generation and dynamic adjustment method. U.S. 12,611,547 B2 (granted 2026) protects our advanced four-phase Digital PEMF waveform architecture and precision pulse generation methods.
A note on the titles: These patents were filed to cover the underlying signal-generation technology across its full range of possible applications, and their titles reflect that original scope. NeuroRinse is not that product. It is a general wellness device, and we make no claim that it treats, cures, or prevents any condition. What the patents establish is that the hardware and waveform architecture are ours, novel, and documented — not that the device does anything a wellness product shouldn't claim.
U.S. Patent No. 8,968,172 B2
U.S. Patent No. 12,611,547 B2
Kantar Home-Use Test (August 2026)
Real performance requires independent validation. Before bringing Mornwolf to Kickstarter, we partnered with global research firm Kantar to conduct a 7-night, 51-person Home-Use Test to measure how our waveform architecture impacts daily recovery and sleep satisfaction.
Instead of relying solely on passive tracking, participants integrated the hardware into their active wind-down routines. By the end of the testing protocol, the results demonstrated a clear structural shift in night quality and morning momentum:
- 73% of users reported an overall improvement in their sleep and recovery cycle by the final day.
- 35% noticed a tangible physical difference within the first 72 hours of use.
- Self-reported "good nights" rose from 34% to 43%.
Feasibility at a Glance
What we're building toward and what research is behind it:
Improved Sleep Quality: Kantar Home-Use Test (Aug 2026, 51 participants): 73% reported improved sleep/recovery by day 7; self-reported "good nights" rose from 34% to 43%. Grounded in earlier Harvard-affiliated pilot research on the underlying Bioboosti platform.
Rebuilding Microcirculation: Peer-reviewed, published research on the Bioboosti platform's PEMF technology, including collaborative studies with Mayo Clinic researchers.
24-hour Continuous Support: Based on aggregate, observational feedback from ~50,000 existing platform users, plus the physiological premise that restorative processes are most active overnight.
The Technology
NeuroRinse is a single, lightweight module worn behind the ear, precision-engineered, minimal, with no bulky headband and no visible wires. It's designed for daytime use: on during deep work, a long meeting, or whenever the day starts to feel heavy.
It uses the same gentle, low-intensity Digital PEMF signal technology, supporting local microcirculation in a way that's meant to feel like quiet background support- not a jolt, not a crash.
From the makers of NeuroRester: our full-day, two-module recovery system (day, pre-sleep, and overnight support) NeuroRinse takes that same underlying technology and distills it into one module, designed to work for you around the clock - daytime reset, nighttime calm.
Our Goal
NeuroRinse is done. After fifteen years developing the underlying technology, we've completed a fully working one module system. This isn't a rendering or an early build; it's the actual product, tested and functioning exactly as described.
What's left isn't engineering — it's scaling. Between now and shipping, we need to place our production order, secure long-lead components, and run the finished design through manufacturing and quality testing. That's a matter of months, not more years of development.
Our funding goal is $10,000. We want to be straightforward about what that figure represents: it's the threshold that lets this campaign move forward, not the full cost of bringing NeuroRinse to market. The majority of development and tooling investment is already committed and funded from within the business. What we need from Kickstarter is confirmation that the demand is real, and a first group of backers whose orders justify committing to that production run.
Funding beyond the goal goes directly toward accelerating a second production run — shorter waits for backers after the initial batch, and a faster path to general availability.
We're being deliberate about scale, not cautious about readiness. The early tiers are capped because our first manufacturing run is genuinely limited, not to manufacture urgency. We'd rather ship a smaller number of units well, to a group close enough to us that their feedback shapes the next version, than overcommit and miss dates.
The technology is proven. The product is built. What we're asking you to fund is the last stretch — turning a finished design into units in hand.
Safety & Compliance
Engineered for Safety. Designed Under FDA General Wellness Guidance.
NeuroRinse is designed in accordance with FDA guidance for General Wellness products.
Safety Profile:
- Non-invasive & non-implanted: Does not penetrate skin
- Low-intensity Digital PEMF: Non-stimulating technology with no thermal effect or no ionizing radiation.
- Established Platform: Approximately 50,000 users of Bioboosti®-platform devices to date.
General Wellness Claims (FDA Category 1 Aligned):
- Supports relaxation and helps manage everyday stress.
- Supports the healthy flow of Qi (vital energy) and circulatory comfort.
- Helps maintain daily energy as part of a healthy lifestyle.
- Supports a general sense of wellbeing and morning energy.
Contraindications
Not for use by individuals with implanted cardiac pacemakers, implantable cardioverter defibrillators, deep brain stimulators or other neurostimulators; during pregnancy; or in the presence of active hemorrhage. Consult your healthcare provider if you have any medical condition or are undergoing treatment.
NeuroRinse is a general wellness device. It is not intended to diagnose, treat, cure, or prevent any disease.
Our Pledge
Commitment to Transparency
Building a device like this involves real-world execution risk. We've reduced it substantially through fifteen years of platform heritage and existing manufacturing capability for Bioboosti® and NeuroRester®, but honest risks remain:
- Manufacturing & Supply Chain:
Component lead times and fine-tuning high-precision injection molds can occasionally encounter unforeseen supply chain fluctuations. We mitigate this by working with experienced manufacturing partners and placing long-lead component orders early.
- App & Ecosystem Integration:
Ensuring reliable synchronization with Apple Health and Google Health Connect across many device models requires rigorous software testing and app store review cycles.
- International Shipping & Customs:
Global logistics and customs clearance procedures can sometimes introduce minor transit delays.
- Your Data:
NeuroRinsecollects wearable health data to personalize device sessions. For information on how your data is collected, used, and protected, visit support.neurorester.com.
- Regulatory Status:
NeuroRinse is engineered as a general wellness device compliant with FDA General Wellness Guidance and applicable consumer safety standards. It does not require medical device pre-market clearance.
Our Promise: If unexpected delays occur, we will provide open, honest, and regular updates on our progress, the challenges, and how we're addressing them.
Return & Refund Policy
We want Kickstarter backers to support NeuroRinse with confidence. Our refund and return policy is divided into the following two situations:
1. Before Your Reward Has Shipped
While the Kickstarter campaign is live, you may cancel or modify your pledge directly through your Kickstarter account.
After the campaign has ended and your payment has been collected, you may still request cancellation before your reward has been handed over to the shipping carrier.
If your cancellation request is approved before shipment, we will refund: the full amount paid for your reward items; and any shipping charges collected for the canceled reward.
Once the reward has been handed over to the shipping carrier, the order can no longer be canceled under the pre-shipment cancellation policy. You may instead request a return after delivery under our 30-day return policy below.
2. After Your Reward Has Been Delivered
Kickstarter backers may request a return within 30 calendar days from the date the shipping carrier confirms delivery.
The product may be opened and reasonably tested during this period. To qualify for a refund: all NeuroRinse modules, charging accessories, cables and other included components must be returned; the product must not have been damaged through misuse, abuse, accidental damage, loss or unauthorized modification; and the return must be authorized by our support team before it is shipped back.
For a standard change-of-mind return, we will refund the amount paid for the returned reward items. Original shipping charges are non-refundable, and the backer is responsible for return shipping costs.
Original packaging is preferred but is not required, provided that all items are securely packaged and protected during return shipping.
If the reward arrives defective, damaged in transit or materially different from the reward selected, NeuroRester will cover the applicable return shipping cost and offer a replacement or an appropriate refund.
To request a cancellation or return, please contact support@neurorester.com and provide: your Kickstarter account email; your backer number; your reward selection; and the reason for the request.
Please do not return a product without first receiving return authorization and shipping instructions from our support team.
Once an eligible return has been received and inspected, we will initiate the refund within 5–10 business days. Refunds will be sent to the original payment method. Additional processing time may be required by Kickstarter, the payment processor or the backer's financial institution.
Customs duties, import taxes, brokerage fees and other charges paid directly to government authorities or third parties are non-refundable, except where required by applicable law.
Disclaimer
We are committed to providing the best and most reliable shipping experience. To ensure accurate pricing, shipping fees are NOT included in your Kickstarter pledge.
After the campaign ends, you will receive a survey link via email (e.g., BackerKit/ PledgeBox). There, you will provide your shipping address, and the exact shipping cost will be calculated and collected.
Duties, Taxes and Custom Charges are set by your local government and are the sole responsibility of the recipient upon delivery.
For EU, UK, and CA Backers (DDP): To save you from expensive surprise customs fees and courier handling charges at your door, we will use a Delivered Duty Paid (DDP) method. Your local VAT/Taxes and the new 2026 EU customs fees will be clearly calculated and collected together with your shipping fee in the survey.
